EcoDrugPlus

Adenosine Receptor A1

Ensembl ID : ENSONIG00000028739
Gene Symbol: LOC100698410
4 Cross references
173 Possible Orthologues:

Adenosine Receptor A3

Ensembl ID : ENSONIG00000012328
Gene Symbol: LOC100691101
2 Cross references
39 Possible Orthologues:

Adenosine Receptor A3

Ensembl ID : ENSONIG00000039464
Gene Symbol: LOC100703648
2 Cross references
137 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSONIG00000028317
Gene Symbol: ADRA1B
3 Cross references
191 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSONIG00000036711
Gene Symbol: ADRA1B
1 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSONIG00000014583
Gene Symbol: ADRA1D
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSONIG00000021117
Gene Symbol: ADRA2A
4 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSONIG00000020723
Gene Symbol: ADRA2A
4 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSONIG00000020433
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSONIG00000020834
Gene Symbol: ADRA2C
4 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSONIG00000020665
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSONIG00000036346
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).